Upacicalcet sodium is an intravenous calcimimetic agent. Upacicalcet suppresses excessive parathyroid hormone (PTH) secretion, thereby lowering blood PTH levels, by acting directly on parathyroid cell membrane calcium-sensing receptors. Upacicalcet can be used for researching the disease of secondary hyperparathyroidism (SHPT).
性状
Solid
IC50 & Target[1][2]
calcium-sensing receptors
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
-20°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
参考文献
[1]. Hoy SM. Upacicalcet: First Approval. Drugs. 2021;81(13):1593-1596.
溶解度数据
In Vitro: DMSO : 100 mg/mL (267.56 mM; Need ultrasonic)配制储备液